163318	1975	evaluation dye exclusion colony inhibition technique detection polyoma specific cell mediate immunity cellular immunity direct polyoma virus induced antigen observe c3h hej splenic lymphoid cell ncbitaxon10090 sensitize short term immunization schedule syngeneic polyoma 4198 4198v meshd009369 cell polyoma specificity response show presentation splenic cell dba 2j animal meshd014412 cytotoxic c3h 4198 4198v cell cell another cell line c3h origin polyoma specific response syngeneic system detectable dye exclusion assay colony inhibition procedure colony inhibition cell observe sensitize lymphoid cell allogeneic syngeneic system
163319	1975	potentiation ncbitaxon10515 associate virus ncbitaxon10310 transform cell ncbitaxon10310 ncbitaxon10310 transform cell line 333 8 9 inoculate adeno virus associate virus type 3 aav 3 examine immunofluorescent fa technique evidence aav 3 antigen synthesis antiserum make three meshd012967 dissociate structural polypeptide vp 1 vp 2 vp 3 aav 3 unit aav 3 virion use examine search aav 3 fa stainable antigen synthesize cell 333 8 9 cell inoculate aav 3 alone produce fa stainable antigen detect vp 1 vp 3 unit virion antiserum vp 2 antiserum coinfection aav 3 inoculate 333 8 9 cell with either ncbitaxon10515 ncbitaxon10515 ncbitaxon10298 ncbitaxon10298 helper permit formation fa stainable antigen detect antiserum include vp 2 antiserum contrast 333 8 9 cell bhk 21 cell fail produce aav 3 fa stainable antigen inoculate aav 3 alone addition either ncbitaxon10515 ncbitaxon10298 helper result formation antigen detect vp unit virion antiserum result suggest 333 8 9 cell enhance formation two three aav 3 structural polypeptide incomplete potentiation related ncbitaxon10310 genetic material possess cell
163320	1975	biochemical property ncbitaxon1891767 transform 3t3 cell mitochondrion mitrochondria isolated ncbitaxon1891767 transform 3t3 nontransformed 3t3 cell compare several biochemical measure transform nontransformed cell mitochondrion identical density additive meshd013395 discontinuous ncbitaxon9913 serum albumin gradient activity several mitochondrion specific enzyme include cytochrome oxidase adenylate kinase meshd009243 meshd009243 cytochrome reductase nadh oxidase similar cell type activity mitochondrial outer membrane enzyme monoamine oxidase virus transform cell mitochondrion reduce 50 nontransformed cell mitochondrion
163322	1975	cell origin meshd009369 induced ncbitaxon1891767 two meshd008223 induced ncbitaxon1891767 ncbitaxon1891767 ncbitaxon10036 study lymphocyte characteristic hymphocytes meshd009369 contain membrane bound immunoglobulin alone 7sgamma2 class neither meshd009369 complement receptor meshd009369 oringinated specific cell population suggest cell type associate ncbitaxon1891767 receptor
163324	1975	elevate immunofluorescence antibody titer several herpesviruses meshd002051 patient high titer alone antibody titer viral capsid antigen four human herpesviruses measure immunofluorescence serum 16 meshd002051 bl patient 16 age sex and locality equal control and 136 family member from the west nile zone uganda among family member titer great 1 4 found 98 herpes simplex virus meshc536395 86 ncbitaxon10335 ncbitaxon10335 100 for cytomegalovirus cmv and 94 for meshd020031 ebv titer patient medium approximately equal 2 log fourfold high equal control ebv ncbitaxon10335 cmv equal 0 001 titer meshc536395 slightly high meshd009369 patient mother patient someuhat high ebv titer 0 05 small equal low than or equal to 0 01 mother control difference patient control family found immunofluorescence method apparently use four human herpesviruses bl patient patient elevate antibody titer ebv cmv ncbitaxon10335 elevate titer three four human herpesviruses due serologic hybridization reaction
163325	1975	unexpected high incidence meshd006528 geneva switzerland age standardize incidence rate meshd006528 plc geneva 9 7 per 100 000 male form four five time high incidence rate report elsewhere europe plc much associate meshd005355 meshd000437 indicate toll plc related meshd000437 meshd008104 great anticipate
163326	1975	induction epstein barr virus associate nuclear antigen vitro transformation human lymphoid cell human lymphoid cell isolated peripheral blood adult cord blood fetal liver spleen bone substance thymus cultivate cell free preparation epstein barr virus ncbitaxon10376 demonstrate transform activity culture examine ncbigene17494235 transfromation permanent lymphoblastoid cell line lcl ncbigene17494235 see culture obtain exogenous ncbitaxon10376 detect day 1 6 addition ncbitaxon10376 frequently day 3 ncbigene17494235 positive cell lymphoblastoid appearance transformation establish lcl become apparent day 12 19 addition ncbitaxon3527 mitogen culture contain ncbitaxon10376 enhance development ncbigene17494235 whereas phytohemagglutinin concanavalin effect neither ncbigene17494235 transfomration observe lymphoid cell fetal thymus fetal spleen bone substance liver cell ncbitaxon10376 regularly induced ncbigene17494235 lcl transformation
163327	1975	isolation tropic type virus reticulum cell meshd009369 induced balb ncbitaxon10090 sjl type virus d1 ncbitaxon11786 mulv tropic type virus isolated spontaneous meshd008228 type rcn sjl ncbitaxon10090 circulate nih swiss ncbitaxon10090 embryo cell culture inject balb ncbitaxon10090 1 day neonatal thymectomy 30 inoculate ncbitaxon10090 developed rcn 5 month whereas none uninoculated control spleen lymph node extract rcn contain ncbitaxon10090 test tropic type virus show e1 mulv isolated high titer 10 5 minus 10 6 xc plaque form unit ml low titer 10 1 minus 10 2 xc plaque form unit ml tropic virus isolated thymectomized ncbitaxon10090 inoculate nontumorous whereas tropic virus detect uninoculated thymectomized ncbitaxon10090 virus isolated nonthymectomized untreated control antigenically viral envelope antigen ncbigene12515 e1 mulv distinct du mulv xvea gross ncbigene12515 hybridization reaction akr mulv ncbigene12515 observe relationship d1 mulv e1 muvl respect oncogenesis viral genome activation discuss
163328	1975	chromosome aberration ncbitaxon10036 embryo cell transform exposure ultraviolet irradiate ncbitaxon10298 2 6 ncbitaxon10036 embryo cell line 14 012 8 1 kos 6 1 333 8 9 333 2 29 ms 4 1 fr 6 1 developed exposure primary culture different strain uv irradiate herpes simplex virus hsv type 1 2 study chromosome aberration cell line show chromosome stability number chromosome maintain narrow range mutant diploid region low incidence polyploid endoreduplications metaphase pulveration extensively fragment chromosome cell line passaged long period time vitro developed marker chromosome suggest clonal type development cell population two cell line 333 8 9 14 012 8 1 show two different marker chromosome large heterochromatic region chromosome abnormal heterochromatic region much appear like large secondary constriction found cell line examine level chromosome breakage low cell line except highly tumorigenic cell line 333 2 29 high incidence cell single double chromatinic body abnormal heterochromatic region occur marker chromosome large secondary constriction see possible chromosomal effect hsv karyotypic stability low incidence give give result uv irradiation hsv
163330	1975	blood group mn antigen precursor normal malignant human breast glandular tissue blood group active substance demonstrate human mammary gland tissue benign malignant lesion precursor thomsen friedenreich antigen occur meshd009369 tissue found regularly 15 gross meshd009369 test precursor tn antigen found regularly meshd009369 breast tissue antigen reactive breast meshd002278 antigen demonstrable 6 benign mammary gland study similarly tn antigen unmasked sialidase treatment healthy breast tissue anti antibody present human serum severely low many meshd001943 patient compare control
163331	1975	quantitative autoradiographic study nucleolus associate rna dna synthesis eclipse phase meshd001357 ncbitaxon9031 fibroblast functional morphological difference sensitivity nucleolus ncbitaxon11886 transform cell new infect cell action meshd003609 meshd000544 demonstrate quantitative light electron microscope autoradiography use investigate function nucleolus early stage meshd007239 pulse exposure low cause meshd000544 increase rna synthesis induced 80 hour fibrillar component nucleolus meshd007239 concomitant increase retention tritiated meshd000544 nucleolus quantitative redistribution intranuclear cytoplasmic dna label see evidence virus induced amplification binding site meshd000544 nucleolar chromatin
163332	1975	effect ncbitaxon1891767 subcutaneous meshd009369 circulate meshd008055 lipoprotein ncbitaxon10036 circulate meshd008055 level lipoprotein normal ncbitaxon10036 determine several time subcutaneous inoculation ncbitaxon1891767 ncbitaxon1891767 strain 2895 fortner meshd008545 cell ncbitaxon1891767 omim102510 induced rapid triphasic peak serum total meshd008055 inhibition prebeta lipoprotein catabolism alpha lipoprotein level decline ratio meshd009369 mass liver wet weight total meshd008055 substance increase significantly normal rate 3h glycerol incorporation meshc009791 precipitable prebeta serum lipoprotein maintain finding serum endogenous lipase lecithin cholesterol acyltransferase lcat cholinesterase activity indicate enzyme primarily responsible meshd009369 induced meshd006949 tumor contain animal selectively increase rate protein meshd008055 excretion urine evidence gross hepatocellular meshd007674 growth ncbitaxon1891767 2895 meshd009369 hamster result large increase rate prebeta lipoprotein synthesis degradation circulate prebeta lipoprotein level elevate much later animal subsequent label decrease lcat activity rather different result obtain meshd008545 level large meshd009369 control effect serum total meshd008055 level lipoprotein normal ncbitaxon10036
163333	1975	inhibition cellular immune response ncbitaxon1891767 meshd009369 cell meshd009369 contain meshd009369 immune ncbitaxon10090 concanavalin effect vivo administer concanavalin con kinetics primary secondary cellular immune response ncbitaxon1891767 transform meshd009369 cell investigate balb ncbitaxon10090 either single initial dose 400 mug con daily cause 50 mug low cell mediate immune response meshd009369 cell progressive growth meshd009369 determine radioisotopic base pad assay immune meshd000275 correlate increase ultimate meshd009369 weight similarly con inhibit antitumor cellular immune response meshd009369 immune animal immune responsiveness give 6 day single injection 400 mug con continuous administration 50 mug con result gradual decline antitumor cellular immune responsiveness reach plateau 5th day splenic lymphocyte con treat immune ncbitaxon10090 fail extract local adoptive change reaction immune responsiveness tend give incubation alpha methyl pyranosyl sugar
163334	1975	property ncbitaxon9031 lymphoblastoid cell line meshd008380 property ncbitaxon9031 lymphoblastoid cell line msb 1 meshd008380 study cell line grow well 41 degree medium rpmi 1640 supplement 10 ncbitaxon9913 fetal serum double time 8 12 hour cell grown stationary suspension culture bind vessel morphology typical lymphoblast 37 degree cell line grow initially cease fraction several subculture subculture maintain 48 72 hour 1 2 cell produce ncbitaxon10390 ncbitaxon10390 specific intracellular mambrane antigen contain ncbitaxon39059 particle examine electron microscope cocultivation cell duck ncbitaxon9031 embryo fibroblast culture result meshc564591 production microplaques typical ncbitaxon10390 peripheral nerve lesion meshd009369 characteristic marek meshd010300 cause inoculation susceptible chick msb 1 cell duck cell infect strain bc 1 ncbitaxon10390 recover msb 1 cell line specific meshd009369 produce site inoculation meshd007239 readily transmit cagemates meshd009369 produce skeletal muscle appear largely virus induced msb 1 cell line free type virus particle
163335	1975	estrogen dependent vitro stimulation rna synthesis hormone dependent mammary meshd009369 ncbitaxon10116 incubation estradiol vitro 25 degree homogenate carcinogen induced mammary meshd009369 ovariectomized ncbitaxon10116 stimulate meshd008274 dependent rna polymerase activity nucleus hormone dependent meshd006816 regress meshd009369 effect activity nucleus hormone autonomous hi grow meshd009369 recombination nucleus cytosol fraction meshd006816 meshc538424 indicate vitro effect meshd004958 subsequent meshd009369 nuclear rna synthesis require ncbigene24890 contain cytosol specific nucleus meshd006816 found first direct vitro effect estrogen specific biochemical process meshd006816 mammary meshd009369
163336	1975	meshd008223 associate ncbitaxon10381 ncbitaxon9505 two case meshd008223 one case meshd008232 found group 7 ncbitaxon9505 implication colony single group ncbitaxon10381 ncbitaxon10381 isolated meshd009369 cell 1 meshd008223 cocultivation kidney cell culture imp meshd008232 antibody ncbitaxon10381 found serum sample 2 imp positive ncbitaxon10381 serum 4 clinically normal imp antibody meshd020031 cell found serum animal meshd008223
163337	1975	virus envelope marker mammalian tropism avian rna meshd009369 virus pseudotypes ncbitaxon11276 make avian meshd001357 present five different subgroup pseudotypes show host range restrict avian meshd009369 virus assay avian cell neutralize subgroup specific antiserum efficiency penetration mammalian cell assay use ncbitaxon11276 pseudotypes pseudotypes avian meshd009369 virus belonging subgroup b77 virus able plate mammalian cell high efficiency whereas pseudotypes strain efficiency penetration ncbitaxon11276 pseudotypes 10 2 10 3 fold high efficiency transformation correspond avian meshd009369 virus strain assay mammalian cell suggest postpenetration block expression transformation cell
163344	1975	rna synthesis cell infect herpes simplex virus 9 evidence accumulation abundant symmetric transcript nucleus rna extract nucleus 8 infect cell drove approximately 50 herpes virus dna dna rna hybrid rna preannealed condition provide base pair study rate drove 35 dna dna rna hybrid anneal rna decrease amount rna sequence remain available subsequent hybridization dna upon denaturation preannealed rna rna sequence sequester preannealing become available hybridization dna base pair occur preincubation rna inter molecular since rna concentration dependent involve determine alkaline hydrolysis nuclear viral transcript remain available hybridization preannealing rna subset rna sequence accumulate cytoplasm infect cell addition small amount derive 5 less viral dna complementary transcript detect cytoplasm
163347	1975	meshd003513 induction xenotropic type virus synchronize ncbitaxon10090 cell metabolic requirement virus activation information type rna virus genetically transmit cellular dna normal ncbitaxon10090 cell virus induced exposure cell two class chemical inhibitor protein synthesis halogenated meshd011743 metabolic requirement activation one endogenous virus balb ncbitaxon10090 cell representative class dose study meshd003513 meshd007065 induce virus efficiently culture exponential growth inactive cell stationary phase cell maximally sensitive action dose different time cell cycle virus induction response differentially inhibit condition simultaneous cell exposure inhibitor dna rna synthesis result provide support concept inhibitor protein synthesis halogenated meshd011743 number different mechanism induce type virus free
163363	1975	meshd001102 antigen synthesis modify meshd005166 cell transform t mutant ncbitaxon10090 cell transform t mutant meshd001102 t 3t3 low amount virus specific antigen synthesize high temperature 39 shift permissive temperature 31 cell exhibit level antigen production wild type polyoma transformants antigen produce t transform cell inactivate 39 vitro fast rate produce wild type transform cell observation indicate antigen include virus cod peptide
163364	1975	malignant transformation ncbitaxon10034 kidney cell ncbitaxon1891762 primary ncbitaxon10034 kidney cell transform ncbitaxon1891762 new human papovavirus transform hkbk cell produce ncbitaxon1891762 antigen induced meshd009369 hamster developed antibody ncbitaxon1891762 antigen ncbitaxon1891762 rescue hkbk cell ncbitaxon11191 assist fusion permissive cell one 6 cell line derive hkbk cell induced meshd009369 show characteristic hkbk cell
163369	1975	quantitative assay transformation 3t3 cell ncbitaxon10310 interaction ncbitaxon10298 hsv 1 type 2 ncbitaxon10310 swiss 3t3 cell investigate virus induced cytopathic effect developed absence production infectious virus ncbitaxon10310 inactivate uv light 2 4 6 8 min induced cell death absence virus replication cell death detectable infection ncbitaxon10310 inactivate uv irradiation 10 12 14 min 3t3 cell infect uv inactivate virus 10 12 min remain double past reach inhibit monolayer usually associate cell infection 3t3 cell uv irradiate usv 2 induced development transform focus transform cell epithelioid fibroblastoid morphology identify isolated ncbitaxon10310 transform cell line contain ncbitaxon10310 specific antigen detectable immunofluorescence technique maximal frequency ncbitaxon10310 induced transformation 3 time 105 pfu per transform focus observe transformation inhibit pretreatment virus specific antiserum type particle detect five cell culture passage transformation ncbitaxon10310 type virus particle detect 10 cell culture passage ncbitaxon10310 transform cell line
163372	1975	interspersion sequence ncbitaxon11866 rna rapidly hybridize meshd007938 ncbitaxon9031 cell dna fluid hybridization progressively small fragment 35s 27s 15 5 12 5 8 poly select ncbitaxon11866 rna excess dna meshd007938 ncbitaxon9031 myeloblast reveal size rna contain sequence complementary slow rapidly hybridize cellular dna sequence apparently rna sequence hybridize rapidly excess cellular dna restrict one region ncbitaxon11866 35s rna rather appear randomly circulate total 35s ncbitaxon11866 rna particle position 200 base meshd011061 tract 3 last rna
163374	1975	ncbitaxon1891767 function require administration maintenance malignant transformation member five class temperature sensitive ncbitaxon1891767 mutant test ability transform ncbitaxon10029 lung cell two measure transformation use ability form clone medium low serum concentration ability overgrow monolayer mutant fail transform restrictive temperature subconfluent ncbitaxon10029 lung monolayers use mutant fail transform restrictive temperature confluent monolayers deplete medium use transform clone select purify recloning examine temperature cell line induced mutant lose transform phenotype high temperature function require maintenance transform phenotype ncbitaxon10029 lung cell function know require induction viral dna synthesis permissive cell therefore transformation result presentation cell capacity aberrant induction dna replication
163375	1975	function ncbitaxon1891767 gene transform infection productive infection ncbitaxon1891767 gene know determine induction viral dna replication control synthesis late viral rna function gene transform infection investigate infection form cell specie 6 independently isolated temperature sensitive mutant belonging complementation group mutant fail initiate stable transformation cell continuous infection restrictive temperature administration transformation permissive temperature subsequent shift restrictive temperature block function two distinct virus cell interaction identify one case increase colony form capacity transform cell remain stable temperature shift case temperature shift decrease capacity transform cell form colony level untransformed control cell result virus cell interaction depend nature mutant give cell specie specie cell transform give mutant finding suggest transformation process require two distinct case related gene expression
163376	1975	role ncbitaxon1891767 gene function maintenance transformation ncbitaxon10090 ncbitaxon10034 human cell transform permissive temperature mutant ncbitaxon1891767 ncbitaxon1891767 complementation group rate control role gene function transformation follow parameter transformation monitor transform cell permissive nonpermissive condition morphology saturation density colony formation plastic cell monolayers soft meshd000362 uptake meshd006601 expression meshd009369 surface antigen cell transform temperature sensitive t mutant exhibit phenotype transform cell nonrestrictive temperature parameter study grown restrictive temperature phenotypically similar normal untransformed cell growth curve show t mutant transform cell exhibit growth characteristic wild type virus transform cell permissive temperature resemble normal cell rate restrictive condition 3 51 fold reduction level saturation density colony formation uptake meshd006601 mutant transform cell elevate temperature compare grown permissive temperature mutant transform cell nonpermissive temperature able produce transform focus shift permissive condition indicate phenotypically revert cell inactive viable regress reversible case ncbitaxon1891767 antigen present cell temperature antigen detect cell maintain nonpremissive temperature wild type virus transform cell exhbited transform cell exhibit transform phenotype grown either restrictive nonrestrictive condition thers result indicate ncbitaxon1891767 group mutant transform cell temperature sensitive maintenance growth property characteristic transformation virus rescue mutant transform cell transfection method t suggest ncbitaxon1891767 gene function rather cellular one responsible t behavior cell
163377	1975	ncbitaxon1891767 gene function maintenance transformation transformants isolated infection ncbitaxon10116 embryo cell 33 either wild type ncbitaxon1891767 temperature sensitive gene mutant tsa7 tsa28 examination property usually associate transformation growth 1 serum growth rate saturation density morphology show property temperature dependent meshc012589 transformants characterize temperature dependent wild type transformants examine good characterize tsa transformants expression antigen appear temperature dependent information suggest active function require maintenance transformation cell lytic cycle function involve induction dna synthesis transformation ncbitaxon1891767 direct result presentation ncbitaxon1891767 replicon presence dna initiator function cause cell show transform phenotype
163379	1975	detection virus specific antigen surface herpes simplex virus transform cell virion associate antigen cp 1 detect surface ncbitaxon10034 cell transformation inactivate ncbitaxon10298 presence cp 1 antigen cell correlate synthesis antibody tumorbearing hamster able neutralize herpes simplex virus type 1 2
163380	1975	ectopic production ncbigene2056 meshd009396 patient relation clinical stage disease activity measurement ncbigene2056 level reach urine plasma meshd009369 extract specimen 27 meshd009396 patient good correlation stage disease clinical judgment inactive respond meshc565785 ncbigene2056 level line ncbigene2056 level believe reflect ectopic hormone production primary secondary meshd009369 since ncbigene2056 hormone assay meshd009396 patient associate meshd011086 believe meshd009396 associate ncbigene2056 differ manner hormone produce usually human possible state associate secondary meshd011086 etythropoietin assay purification technical development additional widespread assistance clinical classification subsequent management meshd009369 state study support biological possible
163448	1975	computerize axial tomography clinicopathologic correlation august 1973 april 1974 750 patient computerize axial tomography ct scan massachusetts general hospital ten brain previously ct scan patient group section level scan nearly exact correlation found anatomic location extent intracranial lesion demonstrate ct scan finding gross microscopic pathologic examination case primary meshd001932 meshd006849 meshd002543 meshd007511 meshd002544 meshd010871 thermal burn meshd001927 finding concentration value mu 47 pathologically control process show high concentration meshd002543 meshd002118 contain meshd009369 readily separable process base mu value alone abnormal mu value primary meshd001932 meshd004487 meshd007238 difficult differentiate normal spinal fluid white matter
163453	1975	isolation herpes simplex virus cerebrospinal fluid meshd008587 two case meshd008581 report etiologic diagnosis establish isolation herpes simplex virus cerebrospinal fluid patient afebrile meshd001919 culture obtain one patient mean meshd007938 see total others literature show value culture herpes simplex virus cerebrospinal fluid
163460	1975	odontogenic meshd018254 comprehensive study 20 new case 20 new case meshc538229 total literature bring total number report case 152 clinical radiographic microscopic finding case support previously report information lesion odontogenic meshd018254 benign lesion grow residue odontogenic epithelium treat conservatively indication lesion recur histogenesis lesion well origin esinophilic droplet material discuss
163461	1975	meshc538445 submandibular gland meshc538445 major salivary gland observe report literature much site origin primary meshd009369 skin mucosal line direct neck structure meshd009369 usually meshd008545 meshd002294 frequently involve salivary gland parotid submandibular sublingual gland rarely involve meshd004194 secondary lesion grow distant primary meshd009369 occasionally involve parotid gland highly rare major salivary gland second report case metastatic meshd002277 submandibular gland present case previously report case similar primary meshd009369 grow breast clinical morphological feature review
163487	1975	survival form meshd016399 adenylate cyclase meshd007545 stimulator adenylate cyclase use select stable form clone ncbitaxon10090 meshd008228 enzyme inability four different stimulators activate meshd000242 synthesis form contrast wild type parent involve normal cell one type adenylate cyclase molecular respond different activator
163489	1975	primate type virus ncbigene201161 antigen cell human meshd015470 antigen related major structural protein ncbigene201161 type virus isolated ncbitaxon9519 ncbitaxon9581 ape found peripheral white blood cell five patient meshd015470
163501	1975	mesothelial reaction meshd001195 irritant intraperitoneal injection ten group ncbitaxon10116 inject intraperitoneally one follow suspension measure reference meshd017638 ii acid treat meshd017638 3 meshd017638 plus meshc000499 4 meshd017638 plus meshd012822 meshc000499 6 meshd012822 7 long fibre meshd017638 8 short fibre meshd017638 9 long fibre glass short fibre glass two ncbitaxon10116 group kill 45 xc 150 240 330 day respectively pathology induced different suspension study histologically time interval evidence support chemical induction theory mechanical irritation theory pathogenesis peritoneal meshd008654 found although suspension except meshc000499 cause reactive mesothelium
163502	1975	technique result endoscopic retrograde pancreaticocholangiography preliminary report 140 patient endoscopic retrograde pancreaticocholangiography erpc perform 140 patient primarily black indian first 100 patient study great diagnostic production series suspect obstructive meshd007565 26 diagnosis make 35 patient 40 patient meshd010195 wide duct see 12 patient meshc566837 procedure less helper require patient meshd010146 cessation meshd000438 uptake found operable stricture primary meshd021441 pancreatic function test secretin cholecystokinin pancreozymin correctly diagnose 4 patient meshc566837 erpc normal useful diagnostic production patient meshd012817 15 diagnosis make 23 patient
163509	1975	ultrasound diagnosis meshd006869 due obstruction pelviureteric junction use ultrasound diagnosis upper abdominal mass nonfunctioning kidney described two case congential meshd006869 due obstruction pelviuretic junction present diagnose scan ultrasound examination diagnostic ultrasound simple noninvasive reliable method differentiate cystic solid lesion value whether mass renal extrarenal recommend patient see upper abdominal mass nonfunctioning kidney examine ultrasound
163515	1975	meshd016582 clinical effect ncbitaxon9685 meshd016582 common among ncbitaxon9685 reach high virus transmit readily ncbitaxon9685 cause form haemopoietic meshd008223 common type alimentary multicentric thymic meshd015451 virus involve aetiology certain disease include meshd000740 meshd005921 meshd013577 predisposes ncbitaxon9685 intercurrent meshd007239 many infect ncbitaxon9685 mount immune response support immune condition show serum antibody level feline meshd007938 virus associate cell membrane antigen ncbitaxon9685 titer 32 unlikely support ill effect eliminate meshd015658 result meshd007239 single cat depends immunological competence cat dose virus obtain ability induce immunosuppression ncbitaxon11768 meshd007239 detect examination tissue electron microscopy culture virus plasma tissue united state method use detection meshd007938 antigen peripheral blood leukocyte contain ordinary blood film successful prototype vaccine developed ncbitaxon11768 report line natural history virus disease implicate discus late developed diagnostic method
163523	1975	mixed mullerian meshd009369 uterus ultrastructural study differentiation rhabdomyoblasts present study differentiation rhabdomyoblasts two meshd002296 uterus study electronmicroscopically development rhabdomyoblasts three cell type differentiate 1 undifferentiated mesenchymal cell abundant ribosome cell organelle usually cell already associate strand 2 4 cell occasionally cytoplasmic region numerous nonspecific strand observe 2 light rhabdomyoblast characterize conspicuous nonspecific cytoplasmic strand reduction ribosome specific myofilaments see occasionally cell type 3 differentiate rhabdomyoblasts cell identify clearly presence large number myofibril myofibrillar fragment higly form myofibril see skeletal muscle seldom found transitional form cell type observe function body sarcotubular system process myofibrillar differentiation discuss
163559	1975	cytopathology metastatic meshd001943 comparison make histopathologic cytopathologic appearance 45 case metastatic meshd001943 histopathologic appearance primary meshd009369 metastatic infiltrate duct meshd002277 body cavity fluid present admixture single cell tissue fragment ratio 0 86 1 usually occur tissue fragment well circumscribed cycle oval mass cell true acinus cell tandem system cell metastatic infiltrate duct meshd002277 pleomorphic range 11 5 22 micrometer diameter metastatic infiltrate meshd018275 body cavity fluid present population primarily single cell ratio 13 single cell tissue fragment rare tissue fragment see group generally cohesive cell nuclear form cytoplasm adjacent cell single cell highly high nuclear cellular ratio undifferentiated size range diameter 10 5 14 micrometer presentation metastatic infiltrate meshd018275 similar meshd008223 body cavity fluid cerebrospinal fluid present problem differential diagnosis
163565	1975	virilize meshd018246 reactive gonadotrophin virilize meshd018246 demonstrate yound female urinary meshd015068 excretion subfractions plasma meshd013739 level urinary 17 ketogenic meshd013256 excretion markedly increase meshd003687 primary component androgen excess otherwise meshd018268 found normal evaluate measurement meshd006854 meshd003345 metabolite basal condition active test androgen excess show unexpected response trophic hormone human chorionic gonadotrophin stimulation result label increase androgen production whereas gonadotrophin colony demonstrate mean estrogen inhibition test similarly corticotrophin colony demonstrate corticotrophin stimulation inhibition test removal meshd009369 result normalization androgen production abnormal response upon human chorionic gonadotrophin administration found inappropriate response meshd009369 trophic hormone discuss conclude reliability stimulation inhibition test determine site excessive androgen production accepted reservation
163566	1975	dissociation vivo vitro autonomy human meshd000306 diagnosis meshd003480 due meshd000306 establish patient appropriate examination especially meshd003907 inhibition test ncbigene5443 stimulation test ncbigene5443 measurement radioimmunoassay isolated cell make piece meshd009369 trypsin technique action ncbigene5443 steriodogenesis cell study vitro basal production corticosteroid isolated meshd009369 cell low 0 3 mu plus minus 0 04 2 10 5 cell addition ncbigene5443 induced dose dependent stimulation corticosteroid production meshd009369 cell appear unable produce corticosteroid absence ncbigene5443 maximal production rather low 1 38 mu plus minus 0 07 2 10 5 cell possible explanation discrepancy hormone function test result vitro study give
163571	1975	bronchiolo meshd002282 cell origin bronchiolo meshd002282 least common primary meshd008175 controversy cell origin light electron microscopic study five bronchiolo meshd002282 least two cell type found bronchiolar origin one cell type metaplastic bronchiolar mucous cell bronchiolar base cell ultrastructural feature respiratory ciliated respiratory nonciliated clara cell unusual meshd009369 bronchiolo alveolar region differentiate cell either bronchiole alveolus embryologically common origin information ultrastructure meshd009369 accumulates become apparent meshd002282 must rare occurrence hyperplastic type ii aleveolar epithelial cell found margin meshd009369 mistaken neoplastic cell
163577	1975	role renal meshd000242 control ncbigene13856 production regulatory role meshd000242 meshd000242 production renal hormone rythropoietin follow erythropoietic stimulation cobaltous chloride hexahydrate suggest study rate reveal temporal relationship renal meshd000242 level plasma titer ncbigene13856 addition meshd003035 increase activity ncbigene13856 give enzyme renal erythropoietic factor maximal enzyme activity occur surface meshd000242 level increase ncbigene13856 titer increase renal meshd000242 localize renal cortex meshd003035 stimulate renal cortical adenylate cyclase effect renal cyclic base phosphodiesterase addition meshd000242 3 time 10 6 partially purify cyclic amp dependent protein kinase ncbitaxon10116 kidney inactive preparation renal erythropoietic factor increase ability renal erythropoietic factor give ncbigene24335 information polycythemic ncbitaxon10090 assay bioassay use quantitate erythropoietic activity test substance indicate meshd003994 erythropoietically active respect ability increase radioactive label meshd007501 meshc000615388 incorporation meshd006418 new form red blood cell meshd013806 erythropoietically inactive potentiate erythropoietic effect meshd003035 polycythemic ncbitaxon10090 result suggest meshd000242 play significant role renal production ncbigene13856 follow meshd003035 administration require meshd003035 stimulate renal cortical adenyoate cyclase increase renal meshd000242 level meshd000242 activates protein kinase later stimulate renal erythropoietic factor give ncbigene13856 similar meshd000242 mechanism surgical erythropoietic stimulation exposure meshd000860 meshd011453 treatment
163581	1975	american meshd002051 clinicopathologic study 30 case ii pathologic correlation 30 case meshd008223 undifferentiated burkitt type review old median age predominance presentation abdominal pelvic site rather jaw differentiate series american patient report endemic region africa bone substance involvement invariably consist massive infiltration recognizable smear clot biopsy preparation involvement central nervous system meshd001855 always associate short survival 8 long term survivor meshd008223 apparently restrict single site presentation autopsy consistent detect widespread multiorgan involvement predilection lymphoreticular structure histologic appearance meshd009369 change chemotherapy vary circulate meshd009336 48 hour initial therapy extreme pleomorphism meshd009369 cell 9 month therapy one patient almost gross meshd004832 autopsy organ site show clinically extensively involve meshd009369 prior treatment diagnostic therapeutic implication finding discuss
163582	1975	clinical evaluation patient meshd007244 development antibody component epstein barr virus induced early antigen complex old report emphasize transitory antibody response epstein barr virus ncbitaxon10376 induced early antigen ea course meshd007244 usually direct circulate component ea complex report clinical serologic information present 14 patient meshd007244 respond either alone antibody restrict component ea complex reveal anti initial anti response subside week month onset disease anti remain usually many month many 39 patient long detectable late follow serum spectimens although many patient unremarkable course illness others largely late anti response show unusual prolong clinical expression several complain period 4 28 month recurrent symptom resemble see acute stage disease presence anti relatively high continuous titer antibody eb viral capsid antigen vca reflect common persistent ncbitaxon10376 activity number report recurrent symptom
163583	1975	meshd005198 adult expression latent form meshd009101 review 17 case meshd005198 bence jones meshd011507 meshd009101 meshd000686 include three new case report detail emerges well determine determine characteristic case diagnosis meshd005198 precede development meshd000686 meshd009101 precede development meshd005198 report patient bence jones meshd011507 detect electrophoresis immunoelectrophoresis 7 case bence jones protein type kappa type serum protein monoclonal abnormality bone substance renal sample half patient crystalline cytoplasmic inclusion body present lymphoplasmacytic component renal tubular cell suggest patient meshd005198 bence jones meshd011507 distinct type plasma cell disorder form monoclonal gammopathy characterize slow progression meshd009369 early phase dominate metabolic complication meshd005198 adult patient meshd005198 carefully investigate presence bence jones protein plasmacytic meshd010265 exclude
163584	1975	aberrant hormone activity meshd009369 gynecologic importance increase number meshd004701 report production hormonal substance generally associate tissue involve direct indirectly interest gynecologist identification occurrence significant diagnosis meshd009382 meshd009369 effect addition observation level aberrant hormone secretion significant therapeutic prognostic measure detection result investigation apparent inappropriate meshd004700 function test case know meshd009369 proof actual production hormone meshd009369 gross identification material question generally require wide biological chemical physical immunological investigation likely mechanism aberrant hormone production meshd009369 derepression genome occurrence chance biosynthetic anomaly coincident neoplastic nuclear alteration hormone active substance interest gynecologist produce condition include gonadotrophin lactogen thyrotropin adrenocortico tropin well meshd002118 circulate erythropoietic substance
163585	1975	ncbigene1084 patient gynecologic meshd009369 finding ncbigene1084 ncbigene1084 plasma much interest currently concomitant search immunological diagnosis test late report shed doubt specificity carcinoembryonic antigen meshd004067 report detail plasma ncbigene1084 value 341 patient vary gynecologic meshd009369 study demonstrate plasma ncbigene1084 elevate fold 50 per cent patient invasive gynecologic meshd009369 incidence positive value appreciably high elevate stage disease specific interest 84 per cent 21 25 patient recurrent meshd002294 neck positive ncbigene1084 value similar result found patient meshd009369 vulva ovary endometrium
163592	1975	human meshd050197 plaque cell meshd007889 cell comparison vitro growth characteristic cell derive human meshd050197 arterial medium compare cell obtain human meshc535516 myometrium respect growth behavior long term cell culture none numerous mutant culture medium include alteration serum concentration origin improve rate cell multiplication vitro longevity uterine cell type neither arterial cell type multiply tissue dissociation enzyme elastase collagenase hyaluronidase replicative life pair 8 sample arterial plaque cell equal less correspond medial cell similar relationship observe 8 pair determine meshd007889 myometrial cell result indicate condition culture vitro cell bona fide fluid meshd009217 finite replicative life pair fluid muscle cell meshd050197 plaque behave similar manner
163597	1975	roentgen problem evaluate atrophic support elderly gastric meshd001284 elderly cause problem interpretation gastrointestinal study 17 case report 8 patient show determine distensibility irregularity distal support simulate meshd002293 6 patient show meshd016055 2 patient show meshd016055 medium awareness phenomenon prevent good error roentgen diagnosis
163611	1975	meshd007340 low circulate ncbigene3630 level diagnostic value ncbigene3630 measurement meshd007003 coexist low plasma immunoreactive ncbigene3630 concentration found 78 year old woman meshd007340 absolute ncbigene3630 level meshd007003 elevate 0 9 1 4 ng ml report 66 5 total circulate immunoreactive insulinlike material produce serum ncbigene3630 concentration together abnormal ncbigene3630 ncbigene3630 ratio show critical importance establish diagnosis islet cell meshd009369 patient
163619	1975	mummify cutaneous mixed meshd009369 34 year old human unusual mummify cutaneous mixed meshd009369 developed short meshd014947 apocrine type meshd009369 cell pilar differentiation explain presence mummification
163621	1975	intracavitary cardiac extension meshd006528 acute meshd059446 62 year old human demonstrate angiographically due meshd009369 later show metastatic meshd006528 resection meshd009369 result total diagnostic relief
163628	1975	histocompatibility antigen solid meshd009369 evaluate relation histocompatibility antigen phenotype solid meshd009369 hl type determine 633 meshd009369 patient compare 489 normal control hl a8 elevate patient meshd002294 meshd008545 meshd000230 high incidence occur patient meshd012468 67 5 17 normal control double increase hl a5 detect patient connective tissue meshd012509 28 incidence 5 9 normal control antigen frequency vary study time diagnosis interval treatment detect certain meshd009369 association increase frequency single hl antigen give clue cause genesis meshd009369
163633	1975	islet cell meshd010190 30 case meshd018273 diagnose memorial hospital study 17 male 13 female patient medium age 44 year meshd009369 site body tail pancreas 25 case primary meshd009369 large 6 cm epigastric meshd010146 meshd007003 meshd007565 frequent primary clinical presentation morphological difference found function nonfunctioning meshd009369 size meshd009369 local tissue infiltration vascular invasion helpful absolute parameter aid differentiation benign meshd018198 20 6 patient metastatic disease time diagnosis liver regional lymph node bone peritoneum common site meshd009362 medium survival 3 9 year cumulative five year survival rate 65
163642	1975	general expression hydrophobic chromatography adsorption elution characteristic skeletal muscle enzyme degree substitution meshd012685 4 alpha alkylamines change gel different hydrophobicity produce protein adsorbed critical hydrophobicity ca 10 12 alkyl residue meshd012685 sphere reach enzyme phosphorylase kinase phosphorylase phosphatase 3 5 camp dependent protein kinase glycogen synthetase phosphorylase successively adsorbed hydrophobicity meshd012685 increase capacity gel enzyme protein general increase exponentially reach plateau value function degree substitution indication restriction hydrophobic substance give protein critical hydrophobicity require adsorb protein either otained manner elongation use alkylamine constant degree substitution additonally hydrophobicity gel increase high binding effect result desorption protein require augmentation meshd012492 concentration elution buffer elution protein hydrophobic matrix described term salt phenomenon since desorption dependent type meshd012492 use ionic strength alone normal ionic interaction major factor adsorption per se rationally control hydrophobicity meshd012685 gel adsorption elution protein establised purification excretion optimally perform
163652	1975	dna binding protein novikoff meshd006528 cell 0 05 meshd012965 6 8 total soluble protein novikoff meshd006528 cell bind rapidly reversibly column contain either heterologous homologous dna adsorbed meshd002482 protein elute buffer contain 2 0 meshd012965 0 5 1 total protein exhibit 7 17 fold preference ncbitaxon10116 dna ncbitaxon562 dna 1 1 5 protein bind dna strongly elution effect 4 0 meshd012965 action deoxyribonuclease treatment column dna binding protein elute 2 0 meshd012965 label 125i 131i characterize meshd012967 meshc016679 gel electrophoresis isoelectric focus experiment indicate dna binding protein present distinct subset total soluble protein many similarity line major component homologous heterologous dna binding fraction
163656	1975	three dna polymerase ncbitaxon10116 meshd001201 cell property enzyme effect rna synthesis reaction three different dna polymerase isolated ncbitaxon10116 meshd001201 cell 1 3 molecular weight dna polymerase polymerase purify soluble fraction cell estimate 142 000 sedimentation meshd013395 gradient molecular weight two dna polymerase polymerase 1 2 purify nuclear membrane chromatin fraction estimate 117 000 44 000 respectively method certain condition meshd011071 strand meshc015465 meshd013936 transcript well polymerase especially nuclear polymerase meshc023826 good template high molecular weight dna polymerase 1 meshd011071 meshc015465 good template addition complementary meshd009843 single strand deoxypolymers transcript high molecular weight polymerase 1 single strand fd phage dna use template polymerization reaction high molecular weight polymerase stimulate concomitant synthesis rna show oligoribonucleotide number primer reaction
163658	1975	human chronic meshd007951 cell line positive philadelphia chromosome cell line derive patient meshd015464 cml described new cell line 175 serial passanges 3 1 2 year period follow characteristic 1 cml cell first proliferate actively since first incubate culture medium double increase total number cell observe first 7 passage cell population increase factor 10 20 every 7 day passage 8 85 20 40 time passage 86 150 40 time 150 passage 2 majority nononucleated cell undifferentiated blast 3 karyotype cell examine show philadelphia ncbigene189 chromosome long acrocentric marker plus meshd000782 giemsa banding study identify ncbigene189 chromosome last deletion long arm chromosome 22 del 22 q12 long acrocentric marker unbalanced reciprocal translocation one chromosome 17 long arm one chromosome 15 4 cml cell produce immunoglobulin free meshd009175 epstein barr virus herpes like virus particle 5 cml cell alkaline phosphatase myeloperoxidase activity engulf inert particle 6 culture cml cell provide constant origin specific antigen cml cell line present alone origin cml cell meaningful indicator meshd009369 clinical experimental study
163662	1975	ultrasound monitor hepatic meshd009362 chemotherapy grey scale ultrasound found sensitive method detect metastatic disease liver two case result chemotherapy monitor ultrasound response treatment differentiate non response ultrasound give useful information chemotherapy make radioisotope examination unreliable
163673	1975	multiple chemotherapeutic approach management meshd018197 preliminary report 1970 stag base surgical resectability meshd056486 devise adjuvant chemotherapy meshd014750 meshd005472 meshd003520 give 7 late case objective study determine unified clinical stag review evaluate effect combination chemotherapy survival elevate disease evaluate early adjunctive combination chemotherapy surgically resectable lesion hopefully prevent metastasis result see 7 patient change short prognosis three female patient present stage 3 4 meshd006528 three male stage ii meshd018197 cause well last free disease 47 month 44 month 28 month one patient meshd018197 lung metastasis diagnosis fail 7 month meshd009369 meshd064420 line use adjunctive combination chemotherapy follow major hepatic resection
163675	1975	clinical test oral form meshd005047 nsc 141540 vp 16 213 clinical test oral form vp 16 213 nsc 141540 semisynthetic meshd011034 undertaken 20 patient treatment first 200 mg day 5 day course double remain period 16 day five patient treat dose double 9 day remain period later 65 patient give 300 400 mg day 5 day remain period 9 day course side effect see include meshd000855 meshd009325 meshd014839 meshd013280 meshd003967 meshd007970 meshd013921 alopecia meshd011537 substernal discomfort palpitation report 18 patient explanation symptom found gross remission cr observe parital remission pr improvement imp see follow small cell meshd002277 lung 10 patient 2 pr 3 imp meshd000230 lung 4 patient 1 pr meshd002282 lung 1 patient 1 imp meshd008654 4 patient 1 imp meshd010051 12 patient 3 pr 3 imp meshd001943 20 patient 4 imp meshd015179 8 patient 2 imp meshd001749 4 patient 2 imp meshd016403 7 patient 2 pr 3 imp meshd015464 1 patient 1 imp
163676	1975	yoshi 864 nsc 102627 meshd000433 3 3 iminodi dimethanesulfonate ester hydrochloride phase 1 study yoshi 864 give push daily time 5 6 week review dose escalation 0 25 mg kg 2 7 mg kg meshd064420 effectiveness first see 1 5 mg kg 20 five course give 16 patient level 16 22 course single meshd015464 meshd013921 meshd007970 occur mean platelet leukocyte nadir occur day 24 29 recovery study 1 2 week 2 3 week respectively hb decrease 11 course 2 7 mg kg meshd009325 meshd014839 last 6 12 day occur 3 7 course 5 coures patient slept 20 hour day 1 meshd003128 2 day two patient meshd002294 1 unknown primary respond patient meshd015464 clinical remission recommend cooperative phase ii study wide spectrum human meshd009369 include meshd008223 meshd015464 undertaken dose level 2 mg kg
163677	1975	meshd004194 child retrospective review clinicopathologic correlation dietary management clinicopathologic feature meshd004194 review 44 child obtain unit abdominal irradiation therapy 1961 1972 institut gustave roussy five 14 long term survivor 36 developed severe delayed meshd011832 meshd007409 occur 2 month completion irradiation previously acute irradiation reaction therapy histologic appearance small bowel time delayed meshd011832 reveal severe meshd014949 lymphatic dilatation moderately slow inflammatory infiltrate patient delayed meshd011832 show label clinical improvement coincident fractionate low residue low fat diet free gluten free milk milk production meshd015212 roentgenographs small bowel biopsy revert normal appearance association diet exacerbation meshd004194 see follow dietary therapy
163678	1975	meshd009396 meshc538614 patient meshd013724 contain meshd009396 meshc538614 described rarity renal tissue meshd013724 possible manner development meshd009396 meshc538614 meshd009369 discuss
163679	1975	syndrome meshd005877 meshd007674 meshc536399 meshd009396 new case fetal meshc536399 described meshd009396 occur study observation provide strong evidence interrelationship meshd007674
163680	1975	synovial meshd012509 neck review study 24 case article review clinicopathologic feature biological behavior 24 case meshd013584 study origin cervical prevertebral connective tissue space demonstrate meshd017703 palpable mass anterior later cervical triangle age 24 patient range 10 51 year median 19 year ten patient woman 14 human hoarseness difficulty breathing swallow first symptom 8 patient meshd009369 alone range 2 10 cm great property microscopically case show characteristic biphasic cellular normal meshd013584 epithelioid meshd005354 like region vary ratio synovioblastic origin meshd009369 support result histochemical stain procedure 1 case examination electron microscope 21 case review information 12 fail 10 meshd009362 9 active free symptom prompt gross surgical removal require prevent complication recurrent meshd009369 growth metastasis
163681	1975	specific estrogen binding ncbitaxon10116 mammary meshd009369 induced 7 12 dimethylbenz meshc034020 experiment undertaken 7 12 dimethylbenz meshc034020 induced mammary meshd009369 ncbitaxon10116 determine whether meshd010051 differentiate base difference estrogen binding capacity meshd009369 vitro vivo result support report show meshd010051 undergo interaction meshd010051 undergo interaction 17beta 3h estradiol specific estrogen binding component vivo vitro described estrogen direct tissue result demonstrate certain 7 12 dimethylbenz meshc034020 induced meshd009369 remain grow ovariectomy host contain significant amount 17beta 3h estradiol bound cytoplasmic well nuclear component sedimentation property component indistinguishable either ovarian dependent 7 12 dimethylbenz meshc034020 induced meshd009369 ncbitaxon10116 uterus cytoplasmic binding component class meshd009369 exhibit similar specificity estrogen appear absolute correlation estrogen binding capacity meshd009369 growth response ovariectomy
163682	1975	autoantibody antilipoprotein specificity meshd007009 patient meshd009369 serum 151 patient form meshd009369 test antibody like activity lipoprotein 18 serum exhibit activity autologous homologous high density lipoprotein 3 exhibit activity autologous homologous low density lipoprotiens antibody like binding show restriction ncbigene2187 fragment igg reactive function lipoprotein particle show appoprotein quantiation serum lipoprotein indicate thehigh density lipoprotien concentration serum meshd009369 patient significantly low psmaller 0 01 antibody present observation suggest autoimmune mechanism responsible decrease high density lipoprotein serum level patient meshd009369
163683	1975	glycosaminoglycans human meshd008113 method suggest analysis meshd006025 isolated human liver combine meshc005062 electrophoresis enzymatic digestion mucopolysaccharidases major component glycossaminoglycans healthy liver meshd006497 meshd006493 65 approximately equal measure meshd003871 hyalauronic acid 13 5 13 respectively small amount meshd002809 component especially meshd002809 meshd006820 markedly increase meshd056486
163684	1975	blastomogenic activity meshc001418 ncbitaxon10090 blastomogenic activity meshc001418 establish prolong administration c57bl 6 cc57br ncbitaxon10090 meshc017648 test blastomogenic condition preparation aqueous result inject dorsal region double weekly 1 5 mg cause total dose per ncbitaxon10090 42 mg meshc001418 50 mg meshc017648 resorptive type many form blastomogenic activity hydroxphenyllactic acid show induced meshd009369 change histogenesis meshd007938 meshd000236 meshd006528 meshd009369 vascular tissue include benign meshd018198 meshd011230
163685	1975	comparative adenylate cyclase activity homogenate plasma membrane fraction meshd008114 5123tc homogenate plasma membrane fraction meshd008114 5123tc ncbitaxon10116 liver study see relation basal activties adenylate cyclase comparative responsiveness enzyme meshd005934 meshd012969 meshd004837 meshd000527 insulin basal adenylate cyclase activity meshd006528 found similar liver adenosine 5 triphosphate concentration 3 2 mm substrate affinity km adenosine 5 triphosphate meshd009369 enzyme like liver finding suggest reduce basal cyclic adenosine 3 5 monophosphate level found occur meshd006528 5123tc probably due decrease basal rate formation cyclic base meshd005934 5 6 mum significantly stimulate adenylate cyclase fraction meshd006528 liver responsiveness meshd009369 enzyme hormone well low responsiveness liver homogenate plasma membrane preparation activity enhance 18 fold relation basal activity liver homogenate compare 6 fold increase meshd009369 plasma membrane preparation meshd005934 increase activity 5 3 5 fold liver meshd006528 respectively meshd012969 10mm contrast meshd005934 increase adenylate cyclase activity approximately extent 10 fold liver meshd006528 preparation meshd004837 100 mum enhance liver meshd006528 homogenate activites 3 4 fold meshd006528 plasma membrane activity 2 fold liver plasma membrane activites increase meshd000527 56 6 mum significantly increase adenylate cyclase activites meshd006528 homogenate 1 5 3 fold respectively plasma membrane preparation insulin 0 7 mum significantly change adenylate cyclase activity preparation
163686	1975	increase activity low km cyclic adenosine 3 5 monophosphate phosphodiesterase plasma membrane meshd008114 5123tc total cyclic adenosine 3 5 monophosphate camp phosphodiesterase activity well activity low high enzyme form investigate homogenate 100 000 supernatant plasma membrane fraction ncbitaxon10116 liver meshd008114 5123tc responsiveness meshd006528 liver plasma membrane low phosphodiesterases imidazole 40 mm theophylline 5mm compare camp concentration 1 7 5 mum total camp phosphodiesterase activity meshd009369 homogenate 100 000 supernatant fraction found less one half liver kinetic study homogenate indicate detect largely due significant reduction 53 activity meshd006528 high enzyme contrast low km camp phosphodiesterase activity meshd009369 homogenate plasma membrane fraction significantly 50 high liver especially apparent meshd000242 concentration 0 5 2 mum since concentration range basal physiological level meshd000242 hepatocytes present result suggest reduce level meshd000242 previously observe meshd006528 5123tc primarily due to increase rate meshd000242 metabolism low km meshd000242 phosphodiesterase plasma membrane meshd009369 meshc029899 increase activity low camp phosphodiesterase liver plasma membrane 22 1 mum meshd000242 38 7 5 mum meshd000242 meshd009369 activity enhance 35 50 respectively 1 7 5 mum meshd000242 meshd013806 inhibit plasma membrane phosphodiesterase activity liver 79 53 meshd000242 concentration 1 7 5 mum respectively meshd006528 activity inhibit 82 1 mum meshd000242 62 7 5 mum meshd000242
163687	1975	estrogen ncbigene5617 colony 7 12 dimethylbenz meshc034020 induced meshd009369 hormonal influence dimethylbenz meshc034020 induced meshd009369 growth investigate detail hormone ablation substitution hormone majority meshd009369 regress follow ablation reactivate subsequent administration estrogen 0 1 5 mug ncbigene5617 2 mg increase number meshd009369 stimulate ncbigene5617 administration delayed basal level meshd004958 0 01 mug addition ncbigene5617 require reactivation meshd009369 meshd009256 competitor estrogen receptor site contain growth large component dimethylbenz meshc034020 induced meshd009369 intact animal fail slow growth ncbigene5617 stimulate meshd009369 withdrawal ncbigene5617 meshd009256 rapid regress meshd009369 occur readministration ncbigene5617 fail activate meshd009369 long 28 day result give good support evidence estrogen play primary role meshd009369 growth interaction ncbigene5617 estrogen meshd009369 site necessary regulatory case related meshd009369 growth
163688	1975	alteration ncbigene25134 activity fetal adult meshd009369 tissue ncbigene25134 activity examine number fetal adult organ well several rodent meshd006528 use enzymatic immunological technique fetal ncbitaxon9986 liver activity first appear low level 20 day postfertilization surface high level birth reach maximal adult liver fast grow meshd006528 activity detect either enzymatic immunological assay detect slow grow meshd006528 well decrease level compare normal adult ncbitaxon10116 liver immunoassay give evidence inactive form enzyme tissue enzymatic activity change rna methyltransferase assay contain simultaneously show inverse relationship ncbigene25134 activity level change rna methyltransferase activity high fetal meshd009369 tissue low normal adult tissue
163689	1975	identification virion vitro l1210 meshd007938 cell line morphological virological immunological technique vitro l1210 cell line contain abundant intracytoplasmic particle numerous type particle small number type particle occasional intracisternal particle intracytoplasmic particle contain spike type fluid surface type particle form budding site type particle developed gradual accululation neucleooid material particle especially type exhibit wide range density cell show strong surface immunofluoresence ncbitaxon10090 mammary meshd009369 virus gross ncbitaxon11786 antigen variable degree cytoplasmic immunoflurescence protein antigen p1 p6 meshd007938 cell culture supernatant purify virus give positive reaction ncbitaxon10090 mammary meshd009369 virus ncbitaxon11786 antiserum immunodiffusion viral particle fail infect c57bl c57bl 6 dba 2f1 hereafter call bd2f1 balb af riiif ncbitaxon10090 howver cell highly tumorigenic bd1f 1 ncbitaxon10090 moderately tumorigenic balb ncbitaxon10090 tumorigenic c57bl af riiif ncbitaxon10090
163690	1975	comparison effect meshd003630 meshd004317 several dna polymerase effect meshd018943 antiboties meshd003630 meshd004317 dna direct activity dna polymerase ncbitaxon11809 ncbitaxon10116 liver high molecular weight specie ncbitaxon562 ncbitaxon1270 determine condition test combine great inhibitory effect viral polymerase cellular polymerase inhibition ncbitaxon11809 dna polymerase meshd003630 competitive respect dna viral dna polymerase conclude inhibition predominatly cause interaction duanomycin primer template dna appreciable reversal meshd003630 induced inhibition polymerase increase mg 2 concentration consistent conclusion derive competition experiment contrast inhibition ncbitaxon10116 liver ncbitaxon1270 dna polymerase essentially noncompetitive dna bacterial enzyme wer less sensitive inhibition dose virion polymerase strong preferential inhibiton viral dna polymerase discuss relation differential sensitivity normal compare meshd009369 cell observe cell line
163691	1975	heritability phytohemagglutinin responsiveness lymphocyte relationship leukemogenesis upon analysis 59 inbred strain 1 hybrid congenic immune ncbitaxon10090 strain strain distribution normal stimulation perippheral ncbitaxon10090 lymphocyte phytohemagglutinin establish use micromethod family dba ncbitaxon10090 low responder phytohemagglutinin whereas c57 family respond well strain pl exhibit well response response lymphocyte lectin govern two less five major gene unknown linkage direct association 2 histocompatibility complex found although indirect influence locus exclude high meshd007938 strain good responder phytohemagglutinin none low responder group strain exhibit spontaneous meshd007938 correlation response lymphocyte expression type rna genome establish cell suspension animal exhibit clinical sign meshd007938 respond weakly lectin
163692	1975	benzo alpha pyrene effect ncbitaxon10090 epithelial cell culture effect meshd001564 growth culture 5 ncbitaxon10090 epithelial cell strain examine epithelial cell highly sensitive cytotoxic action meshd001564 addition activity benzol meshc030984 metabolize system aryl hydrocarbon hydroxylase low highly iducible carcinogen sensitivity cell strain cytotoxic action benjo pyrene decrease inudcibility hydroxylase decrease strong correlation found meshd064420 level uninduced induced hydroxylase value different cell strain compare experiment suggest thehydroxylase significant determine sensitivity epithelial cell cytotoxic action meshd001564 factor modulate sensitivity
163693	1975	peptidyl proline hydroxylase adult produce neoplastic ncbitaxon10116 tissue sensitive assay system optimally supplement tritiated protocollagen substrate cofactor described suitable determine peptidyl proline hydroxylase pph substance wide spectrum ncbitaxon10116 tissue tissue less 50 percent total activity soluble particulate component activity focus mitochondrial microsomal fraction double pretreatment meshd017830 among normal adult tissue lung high total pph activity 2 4 time liver small bowel low 25 percent liver brain lactate mammary gland activity similar skin 60 percent liver fetal tissue contain 3 8 time pph correspond adult tissue much low component total activity soluble four tissue study detail lung liver kidney brain total pph decline rapidly last day gestation brain reach low adult value term whereas three tissue remain decrease course postnatal development injection cortisol fetal ncbitaxon10116 enhance decline pph lung liver skull experiment suggest normal differentiation decline collagen synthesis initiate fetal glucocorticoid secretion maximal 19th gestational day pph activity appear sensitive indicator neoplastic growth renal mammary muscle meshd056486 pph activity 4 10 time high cognate adult tissue level well differentiate slowgrowing meshd009369 activity well high normal grow immature tissue exception skull lung 19 day old fetus
163694	1975	comparison immunogenicity ncbitaxon10034 cell transform adenovirus herpes simplex virus hamster inoculate adenovirus transform cell modify acetoacetylation concanavalin treatment small number support cell partially completely protect challenge 3 time 10 6 support cell treatment vaccine cell meshd007461 meshd016685 neuraminidase plus meshd016685 produce efficient vaccine herpes simplex virus transform cell treat procedure prevent frequently level enhance growth homologous support cell enhancement much great female male hamster protective enhance vaccine induce different level cell mediate immunity detect lymphocytotoxicity test positive homologous transform cell nontransformed ncbitaxon10034 cell contrast specific complement dependent cytotoxic antibody active adenovirus transform cell induced protective acetoacetylated vaccine make adenovirus transform cell antibody present nonprotective inoculation appearance herpes simplex meshd014412 delayed treatment immunostimulant meshd007978 preimmunization ncbitaxon11176 grown sv40 transform cell ncbitaxon11176 grown herpes simplex virus transform cell nonspecific treatment able block herpes simplex virus meshd009369 growth protection meshd000257 follow specific cytotoxic antibody
163697	1975	regulation ncbigene25044 ncbigene25634 hyperplastic nodule ncbitaxon10116 liver meshd004052 meshd015073 feed change level ncbigene25044 ncbigene25634 induced dietary stimulation starvation hyperplastic nodule ncbitaxon10116 liver meshd004052 meshd015073 feed study immuno enzyme histochemical method study perform carcinogenesis combine method enzyme histochemistry radioautography ncbigene25044 observe diffusely cytoplasm original hepatocytes periportal zone induced markedly diethynitrosamine feed slightly meshd015073 feed enzyme deficient inducible hyperplastic nodule produce phase later feed period peak level ncbigene25044 inducibility time majority nodule good correlation observe ncbigene25044 ncbigene25634 elevate level response enviornmental stimulation small group hyperplastic nodule deficiency enzyme remain enzyme induction observe great number hyperplastic nodule persistent meshd008661 see meshd004052 carcinogenesis result provide information change biological nature hyperplastic nodule respect metabolic adaptability enzyme level meshd063646
163698	1975	physicochemical characterization novikoff meshd006528 mitochondrial dna mitochondrial dna mtdna isolated ncbitaxon10116 liver novikoff meshd006528 grown solid meshd009369 cell monolayer culture examine form physicochemical technique buoyant density analytical meshc028019 equilibrium gradient thermal denaturation profile reveal significant difference base report among mtdna isolated liver meshd009369 meshd006528 cell sedimentation neurtral alkaline cscl show difference mtdna size meshd009369 meshd006528 cell mtdna slightly small heterogeneous size liver mtdna molecular form duration measure electron microscope base chemical finding neoplastic mitochondrion contain four five time dna per mitochondrion liver electron microscopy show ratio mtdna complex form catenate dimer oligomers much high meshd009369 18 meshd006528 cell 15 liver 4
163699	1975	presence ncbigene3005 degree human tissue histone hidegree found present number human tissue found 50 total 5 meshc576518 soluble histone human breast 35 thyroid 12 18 adrenal 7 parathyroid tissue measure histone hldegree human tissue large compare amount found ncbitaxon10116 liver 8 ncbitaxon9913 thymus 0 hela cell 0 although measure histone hldegree found vary one type tissue another essentially constant normal hyperplastic neoplastic human thyroid tissue
163700	1975	ncbigene24683 estrogen binding transplantable hormone dependent autonomous ncbitaxon10116 mammary meshd002277 hormone dependent subline transplantable ncbitaxon10116 mammary meshd009369 mtw9 control binding site ncbigene24683 estrogen ncbigene24683 binding saturable similar 2 time 10 9 hormone specific destroyed protease contrast autonomous subline derive parent meshd009369 lose 75 ncbigene24683 estrogen binding site although binding affinity hormone unchanged reduction binding site ncbigene24683 estrogen autonomous line result incomplete identification meshd009369 cell direct circulate hormone subsequent loss hormone dependent growth characteristic
163718	1975	control phosphorylative activity human liver mitochondrion change respiratory enzyme substance 1 oxidative phosphorylation respiratory enzyme activity measure mitochondrion non involve lobe liver 18 patient massive meshd009369 primarily localize one lobe regenerate liver partially hepatectomized ncbitaxon10116 treat meshd002701 2 patient concentration cytochrome change 40 170 pmol mg protein mitochondrion cytochrome concentration 70 pmol mg protein phosphorylative activity per mg mitochondrial protein well high control mitochondrial oxidative phosphorylative activity per unit cytochrome negatively correlate concentration cytochrome patient mitochondrial cytochrome exceed 70 pmol mg protein support partial hepatectomy well give patient mitochondrial cytochrome less 60 pmol mg protein phosphorylative activity low high surgical mortality 3 regenerate liver ncbitaxon10116 treat meshd002701 oxidative phosphorylative activity per unit cytochrome negatively correlate concentration cytochrome 4 suggest increase meshd000255 synthesize activity per unit respiratory assembly basic homeostatic mechanism maintain energy production response increase metabolic load upon hepatic cell
163724	1975	use macrophage electrophoretic mobility test diagnosis meshd016543 author transl macrophage electrophoretic mobility mem test study caspary show ncbigene10216 ncbigene10216 produce specifically sentised blood lymphocyte incubation homologous antigen besides disease cellular immune reaction like multiple meshd009369 show reduction macrophage mobility cell electrophoresis significant inhibition mem test found 30 33 meshd009369 cns meshd005909 meshd001254 meshd008527 meshd004806 meshd009442 meshd008577 meshd005350 show positive result 10 inhibition result meshd009369 meshd010911 meshd003397 differ secondary meshd001932 show great inhibition
163727	1975	vaso active intestinal polypeptide meshd003969 40 year old human meshd003969 refractory watery meshd003967 islet cell meshd010190 islet cell meshd002277 non cell type meshd009362 liver mesenteric lymph node high concentration ncbigene7432 ncbigene7432 demonstrate meshd009369 tissue plasma radioimmunological test surgical removal meshd009369 plasma ncbigene7432 concentration decrease normal immunohistochemical test meshd009369 meshd005767 hormone demonstrate label fluorescence vaso active intestinal polypeptide assume polypeptide largely responsible clinical sign described case severe watery meshd003967 cease glucocorticoid administration
163735	1975	change hormone property transplantable multihormonal meshd010911 mtt f4 hypophysectomy host ncbitaxon10116 transplantable ncbitaxon10116 meshd010911 meshc070243 f4 fail grow ncbitaxon10116 hypophysectomize time transplantation grow meshd013974 treat hypophysectomize ncbitaxon10116 latter ncbitaxon10116 meshd009369 stimulate adrenal extent control ncbitaxon10116 meshd009369 stimulate adrenal extent control ncbitaxon10116 meshd009369 cell isolated incubate vitro hypophysectomize meshd013974 treat ncbitaxon10116 free much less corticotrophin incubation medium meshd009369 cell control ncbitaxon10116 free significantly less growth hormone meshd009369 cell intact intact meshd013974 treat thyroidectomized meshd013974 treat ncbitaxon10116 prolactin free isolated meshd009369 cell vitro group study result suggest hypophysectomy meshd013974 treatment host ncbitaxon10116 selectively influence production hormone meshc070243 f4 transplantable ncbitaxon10116 meshd010911
163742	1975	effect fast control meshd005227 synthesis meshd006528 7777 host liver role long range meshd000214 mitochondrial citrate transporter pyruvate dehydrogenase activity effect fast rate meshd005227 synthesis property mitochondrial citrate transporter pyruvate dehydrogenase activity investigate poorly differentiate meshd006528 7777 host liver preparation property citrate transporter meshd006528 similar meshd008107 exception km liver mitochondrial citrate transporter 248 plus minus 20 mu meshd006528 less 75 mu acid insoluble coa substance 180 plus minus 20 pmol mg protein meshd006528 remain essentially unchanged fast state acid insoluble coa level liver give ncbitaxon10116 720 plus minus 80 pmol mg protein increase 1050 plus minus 50 pmol mg protein fast 36 fast rate lipogenesis percent pyruvate dehydrogenase present active form decrease approximately 80 host liver preparation contrast rate lipogenesis meshd006528 slice decrease fast essentially pyruvate dehydrogenase present active form meshd006528 obtain either give fast animal implication interest identification possible regulatory site control lipogenesis discuss relation observation
163780	1975	relationship serum ncbigene174 severity duration meshd002908 patient meshd006525 use radioimmunoassay detect concentration ncbigene174 low 5 ng per ml 38 176 patient meshd006525 compare health volunteer patient meshd002908 involve liver differentiate two group base histologic classification liver biopsy specimen difference degree frequency increase serum ncbigene174 related severity meshd056486 75 patient lesion viral subacute meshd047508 zone meshd009336 bridge adjacent portal 3 central vein 52 increase value 12 level range 500 3300 ng per ml contrast 28 101 patient bridge meshd009336 increase value none level exceed 500 ng per ml patient subacute meshd047508 comparison ncbigene174 concentration duration meshd002908 indicate protein surface peak level serum sgot decline support serial observation 10 patient increase ncbigene174 serum patient severe meshd056486 occur meshd017093 subside due know feature ncbigene174 intrigue reflect increase serum level protein meshd006525 reflect hepatic regeneration parenchymal damage
163793	1975	course occur persistent feline meshd004832 healthy ncbitaxon11768 ncbitaxon11768 infect ncbitaxon9685 meshd003027 environment follow 23 month development disease evidence alteration hemogram incidence disease development ncbitaxon11768 postive ncbitaxon9685 fivefold high incidence ncbitaxon11768 minus ncbitaxon9685 ten case meshd007938 developed 69 infect ncbitaxon9685 whereas one case meshd007938 occur 59 uninfected ncbitaxon9685 incidence development disease meshd007938 30 4 percent ncbitaxon11768 infect ncbitaxon9685 oppose 6 8 per cent uninfected ncbitaxon9685 result immunosuppressive effect ncbitaxon11768 ncbitaxon11768 infect ncbitaxon9685 evidence subclinical meshd000740 mean packed cell mass total leukocyte number infect uninfected animal mutant see healthy ncbitaxon11768 infect ncbitaxon9685 decrease mean lymphocyte number difference mean lymphocyte number ncbitaxon11768 infect uninfected animal significant 0 999 level finding suggest incubation period feline meshd007938 prolong natural condition increase susceptibility unrelated meshd003141 exists period increase susceptibility apparently associate meshd000740 meshd000275 total leukocyte number
163824	1975	meshd011732 dependent conformational state glycogen phosphorylase examine interconverting enzyme interaction meshd011732 convertible meshd012694 glycogen phosphorylase investigate use specific interconverting enzyme phosphorylase kinase phosphorylase phosphatase effector meshd005947 meshd019298 protein kinase trypsin phosphorylase kinase phosphorylase phosphatase use native protein small influence apoprotein removal peptide contain critical meshd012694 residue give phosphorylase meshd011732 phosphorylase significant effect enzymic interconversion
163829	1975	hapten sandwich label ii immunospecific attachment cell surface marker suitable scan electron microscopy hapten sandwich procedure use immunospecific label cell surface antigen marker visible scan electron microscopy antihapten antibody use associate hapten modify ncbitaxon12242 bushy stunt virus hemocyanin hapten modify human erythrocyte antihapten antibody bridge use associate hapten virus marker hapten modify antibody mammary meshd009369 virus ncbitaxon10090 mammary meshd009369 cell immunoglobulin receptor ncbitaxon10090 splenic lymphocyte case label highly specific technique possible compare morphological feature cell contain differ cell surface antigen examine system specific antigenic site cell surface distribution relation membrane structure microvilli
163832	1975	cell surface change rous sarcoma virus gene expression synchronize cell investigate whether cell surface change associate growth control malignant transformation associate cell cycle ncbitaxon9031 embryo cell synchronize double meshd013936 block examine cell cycle dependent alteration membrane function measure transport meshd003847 meshd014529 meshd013936 meshd008353 cell surface morphology examine scan electron microscopy ability meshd009369 virus gene expression induce transformation specific change membrane function reach follow conclusion high rate meshd003847 transport see transform cell low rate meshd003847 meshd014529 transport characteristic density inhibit cell occur normal grow cell traverse cell cycle although cell cycle dependent change surface morphology reflect correspond change membrane function tumor virus gene expression change cell membrane function stage cell cycle progression cell cycle
163841	1975	interaction delta 5 androstene 3beta 17beta diol meshd004958 dihydrotestosterone receptor human myometrial mammary meshd009369 tissue specific receptor binding meshd004958 ncbigene106478911 meshd013196 meshd013196 study human myometrial tissue human mammary meshd009369 tissue inhibition binding ncbigene106478911 dht ncbigene106478911 meshd013739 meshd013196 dehydroepiandosterone dhea meshd019314 ncbigene6822 meshd000735 5 androstene 3beta 17beta diol adiol test use meshd003911 surface charcoal interval bound free ncbigene106478911 respectively meshd013196 percent binding inhibition direct reference inhibition obtain meshd009256 molar concentration ratio 1 000 ncbigene106478911 binding respectively meshd017373 molar concentration ratio 10 000 meshd013196 binding 15 sample myometrium test receptor found ncbigene106478911 19 sample mammary meshd002277 tissue one show binding activity three sample bind ncbigene106478911 five sample meshd013196 ten sample show binding meshd013256 50 inhibition ncbigene106478911 binding myometrial well meshd009369 tissue require molar concentration ratio 40 adiol 2 000 dhea significant inhibit activity found molar concentration ratio 10 000 ncbigene6822 40 000 see meshd013196 binding meshd015114 active ncbigene106478911 less active substance test meshd015114 therefore one maintain significant inhibit influence molar ratio far beyond physiological range mean adiol interfere receptor level estrogenic stimulation mammary meshd009369 cell
163842	1975	regulation human ncbigene93659 secretion serum meshd003994 malignant trophoblast cell vitro human ncbigene93659 secretion study human malignant trophoblast cell jar line continuous culture radioimmunoassayable ncbigene93659 cell daily culture fluid increase least 3 day 10 newborn ncbitaxon9913 serum 1 mn 6 0 2 dibutyryl cyclic adenosine 3 5 monophosphoric acid dbcamp plus 1 mm theorphylline incubation cell presence serum dbcamp theorphylline result additive stimulation ncbigene93659 secretion 1 day 2 3 day supra additive stimulation observe prevent meshd003609 cell preincubated 2 day absence serum dbcamp plus theorphylline subsequent addition serum result supra additive stimulation ncbigene93659 secretion single day remain presence dbcamp plus meshd013806 necessary stimulation serum finding suggest dbcamp activates slow process require rna synthesis result increase ncbigene93659 secretion serum appear protect ncbigene93659 synthesize system degradation
163843	1975	immunochemical heterogeneity calcitonin plasma calcitonin measure plasma 13 patient medullary throid meshd002277 one patient calcitonin produce islet cell meshd010190 hormone measure simultaneous application two calcitonin antiserum differ specificity calcitonin measurement make gel filtration bio gel p30 fraction plasma sample although two antiserum like sensitivity measurement human calcitonin measure respond differently calcitonin plasma sample one antiserum ld 1 give consistently high estimate hormone concentration plasma patient medullary meshd013964 ld 26 contrast concentration calcitonin islet cell meshd010190 high ld 26 assay multiple gel filtration peak immunoreactive calcitonin activity present thyroidal nonthyroidal calcitonin two different antiserum identify differ immunochemical peak calcitonin activity agiven plasma sample finding demonstrate presence immunochemical heterogeneity plasma calcitonin suggest presence immunological difference thyroidal nonthyroidal calcitonin
